<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36367295</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1479-9731</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><PubDate><Year>2022</Year><Season>Jan-Dec</Season></PubDate></JournalIssue><Title>Chronic respiratory disease</Title><ISOAbbreviation>Chron Respir Dis</ISOAbbreviation></Journal><ArticleTitle>Pulmonary function and Quality of Life in a prospective cohort of (non-) hospitalized COVID-19 pneumonia survivors up to six months.</ArticleTitle><Pagination><StartPage>14799731221114271</StartPage><MedlinePgn>14799731221114271</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">14799731221114271</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/14799731221114271</ELocationID><Abstract><AbstractText Label="OBJECTIVES">A decrease of both diffusion capacity (DLCO) and Quality of Life (QoL) was reported after discharge in hospitalized COVID-19 pneumonia survivors. We studied three and 6&#xa0;month outcomes in hospitalized and non-hospitalized patients.</AbstractText><AbstractText Label="METHODS">COVID-19 pneumonia survivors (<i>n</i> = 317) were categorized into non-hospitalized "moderate" cases (<i>n</i> = 59), hospitalized "severe" cases (<i>n</i> = 180) and ICU-admitted "critical" cases (<i>n</i> = 39). We studied DLCO and QoL (Short Form SF-36 health survey) 3 and 6&#xa0;months after discharge. Data were analyzed using (repeated measures) ANOVA, Kruskal-Wallis or Chi-square test (<i>p</i> &lt; .05).</AbstractText><AbstractText Label="RESULTS">At 3&#xa0;months DLCO was decreased in 44% of moderate-, 56% of severe- and 82% of critical cases (<i>p</i> &lt; .003). Mean DLCO in critical cases (64&#xb1;14%) was lower compared to severe (76 &#xb1; 17%) and moderate (81&#xb1;15%) cases (<i>p</i> &lt; .001). A total of 159/278 patients had a decreased DLCO (&lt;80%), of whom the DLCO improved after 6&#xa0;months in 45% (71/159). However the DLCO did not normalize in the majority (89%) of the cases (63 &#xb1; 10% vs 68&#xb1;10%; <i>p</i> &lt; .001). At 3&#xa0;months, compared to critical cases, moderate cases scored lower on SF-36 domain "general health" (<i>p</i> &lt; .05); both moderate and severe cases scored lower on the domain of "health change" (<i>p</i> &lt; .05). At 6&#xa0;months, there were no differences in SF-36 between the subgroups. Compared to 3&#xa0;months, in all groups "physical functioning" improved; in contrast all groups scored significantly lower on "non-physical" SF-36 domains.</AbstractText><AbstractText Label="CONCLUSION">Three months after COVID-19 pneumonia, DLCO was still decreased in the more severely affected patients, with an incomplete recovery after 6&#xa0;months. At 3&#xa0;months QoL was impaired. At 6&#xa0;months, while "physical functioning" improved, a decrease in "non-physical" QoL was observed but did not differ between the moderate and severely affected patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Roos</LastName><ForeName>Marlise P</ForeName><Initials>MP</Initials><Identifier Source="ORCID">0000-0001-9146-6700</Identifier><AffiliationInfo><Affiliation>Department of Respiratory Medicine, 10215OLVG, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siegerink</LastName><ForeName>Sebastiaan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Psychiatry, 10215Amsterdam UMC and OLVG, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dijkstra</LastName><ForeName>Nynke G</ForeName><Initials>NG</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, 10215OLVG, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Broekman</LastName><ForeName>Birit Fp</ForeName><Initials>BF</Initials><AffiliationInfo><Affiliation>Department of Medical Psychiatry, 10215Amsterdam UMC and OLVG, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brinkman</LastName><ForeName>Kees</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Infectious diseases, 10215OLVG, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonkman</LastName><ForeName>Nini H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Department of Research and Epidemiology, 10215OLVG, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bresser</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, 10215OLVG, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Chron Respir Dis</MedlineTA><NlmUniqueID>101197408</NlmUniqueID><ISSNLinking>1479-9723</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 pneumonia</Keyword><Keyword MajorTopicYN="N">diffusion capacity</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-COVID syndrome</Keyword><Keyword MajorTopicYN="N">post-acute SARS-CoV-2-syndrome</Keyword><Keyword MajorTopicYN="N">pulmonary function</Keyword><Keyword MajorTopicYN="N">quality of life</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>11</Day><Hour>7</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36367295</ArticleId><ArticleId IdType="pmc">PMC9659768</ArticleId><ArticleId IdType="doi">10.1177/14799731221114271</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO . https://covid19.who.int</Citation></Reference><Reference><Citation>van der Sar-van der Brugge S, Talman S, Boonman-de Winter L, et al. Pulmonary function and health-related quality of life after COVID-19 pneumonia. Respir Med 2021; 176: 106272.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7701891</ArticleId><ArticleId IdType="pubmed">33302142</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo X, Jian W, Su Z, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J 2020; 55(6): 2001217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236826</ArticleId><ArticleId IdType="pubmed">32381497</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395(10223): 507&#x2013;513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223): 497&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Toussie D, Voutsinas N, Finkelstein M, et al. Clinical and chest radiography features determine patient outcomes in young and middle-aged adults with COVID-19. Radiology 2020; 297(1): E197&#x2013;E206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7507999</ArticleId><ArticleId IdType="pubmed">32407255</ArticleId></ArticleIdList></Reference><Reference><Citation>Prokop M, van Everdingen W, van Rees Vellinga T, et al. CO-RADS: a categorical CT assessment scheme for patients suspected of having COVID-19-definition and evaluation. Radiology 2020; 296(2): E97&#x2013;E104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233402</ArticleId><ArticleId IdType="pubmed">32339082</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiology Working Group for NCIP Epidemic Response. Chinese Center for Disease Control and Prevention . Novel Coronavirus pneumonia emergency response epidemiology team the epidemiological characteristics of an outbreak of 2019 novel Coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi 2020; 41: 145&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pubmed">32064853</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA 2020; 323(13): 1239&#x2013;1242. Epub 2020/02/25. pmid:32091533.</Citation><ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed H, Patel K, Greenwood DC, et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: a systematic review and meta-analysis. J Rehabil Med 2020; 52(5): jrm00063.</Citation><ArticleIdList><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngai JC, Ko FW, Ng SS, et al. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology 2010; 15(3): 543&#x2013;550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7192220</ArticleId><ArticleId IdType="pubmed">20337995</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiumello D, Coppola S, Froio S, et al. What&#x2019;s next after ARDS: long-term outcomes. Respir Care 2016; 61(5): 689&#x2013;699.</Citation><ArticleIdList><ArticleId IdType="pubmed">27121623</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Borst B, Peters JB, Brink M, et al. Comprehensive health assessment three months after recovery from acute COVID-19. Clin Infect Dis 2020; 73(5): e1089.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717214</ArticleId><ArticleId IdType="pubmed">33220049</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler S. A., Ebner L, Aubry-Beigelman C, et al. Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J 2021; 57(4): 2003690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8082329</ArticleId><ArticleId IdType="pubmed">33419891</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M., Soddu D, Balbo PE, et al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw Open 2021; 4(1): e2036142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Yao Q, Gu X, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet 2021; 398(10302): 747&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Heightman M, Prashar J, Hillman TE, et al. Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals. BMJ Open Respir Res 2021; 8: e001041. DOI: 10.1136/bmjresp-2021-001041</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2021-001041</ArticleId><ArticleId IdType="pmc">PMC8587466</ArticleId><ArticleId IdType="pubmed">34764200</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organisation . Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected Interim guidance 13 March 2020. Geneva, Switzerland: World Health Organisation (WHO), 2020.</Citation></Reference><Reference><Citation>de Roos MP, Kilsdonk ID, Hekking PW, et al. Chest computed tomography and alveolar-arterial oxygen gradient as rapid tools to diagnose and triage mildly symptomatic COVID-19 pneumonia patients. ERJ Open Res 2021; 7(1): 00737&#x2013;02020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7898029</ArticleId><ArticleId IdType="pubmed">33718488</ArticleId></ArticleIdList></Reference><Reference><Citation>Aaronson NK, Muller M, Cohen PD, et al. Translation, validation, and norming of the Dutch language version of the SF-36 health survey in community and chronic disease populations. J Clin Epidemiol 1998; 51(11): 1055&#x2013;1068.</Citation><ArticleIdList><ArticleId IdType="pubmed">9817123</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham BL, Steenbruggen I, Miller MR, et al. Standardization of spirometry 2019 update. An Official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med 2019; 200(8): e70&#x2013;e88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6794117</ArticleId><ArticleId IdType="pubmed">31613151</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham BL, Brusasco V, Burgos F, et al. 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J 2017; 49(1): 1600016.</Citation><ArticleIdList><ArticleId IdType="pubmed">28049168</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26(3): 511&#x2013;522.</Citation><ArticleIdList><ArticleId IdType="pubmed">16135736</ArticleId></ArticleIdList></Reference><Reference><Citation>Frija-Masson J, Debray MP, Gilbert M, et al. Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection. Eur Respir J 2020; 56(2): 2001754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7301832</ArticleId><ArticleId IdType="pubmed">32554533</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao YM, Shang YM, Song WB, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine 2020; 25: 100463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Truffaut L, Demey L, Bruyneel AV, et al. Post-discharge critical COVID-19 lung function related to severity of radiologic lung involvement at admission. Respir Res 2021; 22(1): 29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7819622</ArticleId><ArticleId IdType="pubmed">33478527</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie L, Liu Y, Xiao Y, et al. Follow-up study on pulmonary function and lung radiographic changes in rehabilitating severe acute respiratory syndrome patients after discharge. Chest 2005; 127(6): 2119&#x2013;2124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094359</ArticleId><ArticleId IdType="pubmed">15947329</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng CK, Chan JW, Kwan TL, et al. Six month radiological and physiological outcomes in severe acute respiratory syndrome (SARS) survivors. Thorax 2004; 59(10): 889&#x2013;891.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1746851</ArticleId><ArticleId IdType="pubmed">15454656</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui DS, Joynt GM, Wong KT, et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax 2005; 60(5): 401&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1758905</ArticleId><ArticleId IdType="pubmed">15860716</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui DS, Wong KT, Ko FW, et al. The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest 2005; 128(4): 2247&#x2013;2261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094276</ArticleId><ArticleId IdType="pubmed">16236881</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F, et al. Persistent symptoms in patients after acute COVID-19. JAMA 2020; 324(6): 603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Pan R, Wan X, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 Coronavirus Disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health 2020; 17(5): 1729.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7084952</ArticleId><ArticleId IdType="pubmed">32155789</ArticleId></ArticleIdList></Reference><Reference><Citation>Goertz YMJ, Van Herck M, Delbressine JM, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res 2020; 6(4): 00542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M., Palese A, Venturini M, et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect 2021; 27(10): 1507&#x2013;1513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol 2021; 93(2): 1013&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur 2021; 6: 100122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>